InvestorsHub Logo

louieblouie

09/03/20 3:10 PM

#295830 RE: alm2 #295793

Personally I'm all for releasing the kraken and dumping vascepa as an OTC dietary supplement in the US at this point. Pull the rug out from generics and focus on nothing but volume.

marjac

09/03/20 11:04 PM

#296064 RE: alm2 #295793

Hi alm2. I am every bit as disappointed as you, on multiple levels. I consider courthouses to be cathedrals, and judges to be high level dispensers of justice, but when they reasonably and objectively fail to adhere to those lofty expectations, I hurt inside.

There are probably several things that can be done to wage war with the generics, but I am not so sure if any of that will help the stock price. As I explained previously, En banc and SCOTUS are not realistic possibilities. I believe that the second appeal will be dismissed based upon the Consent Order where the parties agreed that it would be bound by the results of the first appeal.

I do not see injunctive relief because the generics have FDA approved ANDAs, and won at both the District Court and Federal Circuit levels.